Literature DB >> 15530686

Hepatitis B vaccination in a hyper-endemic tribal community from India: assessment after three years.

M V Murhekar1, K M Murhekar, S C Sehgal.   

Abstract

Hepatitis B infection is highly endemic among the primitive tribes of Andaman and Nicobar Islands, India and it is necessary to initiate hepatitis B vaccination for control of this infection. A pilot project of mass hepatitis B vaccination using indigenously developed vaccine was initiated among Nicobarese tribe of Car Nicobar Island. Sero-protection rates after second and third year were 89% and 85.5%, respectively. The rate of chronic infection in the vaccinated population after three years was 1.86% compared to the pre-vaccination rate of 20.7%. Considering high sero-protection rates and low cost, the indigenous vaccine could be used for vaccination programme in this tribal community.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530686     DOI: 10.1016/j.vaccine.2004.05.038

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

Review 1.  Calculating prevalence of hepatitis B in India: using population weights to look for publication bias in conventional meta-analysis.

Authors:  Ashish Batham; Manoj Anand Gupta; Pallav Rastogi; Shubham Garg; V Sreenivas; Jacob M Puliyel
Journal:  Indian J Pediatr       Date:  2010-01-28       Impact factor: 1.967

2.  Status of hepatitis B infection - a decade after hepatitis B vaccination of susceptible Nicobarese, an indigenous tribe of Andaman & Nicobar (A&N) islands with high hepatitis B endemicity.

Authors:  Haimanti Bhattacharya; Debdutta Bhattacharya; S R Ghosal; Subarna Roy; A P Sugunan
Journal:  Indian J Med Res       Date:  2015-05       Impact factor: 2.375

3.  Authors' response.

Authors:  A P Sugunan; Haimanti Bhattacharya; Debdutta Bhattacharya; A Mandal; S R Ghosal; R C Rao; A K Mandal
Journal:  Indian J Med Res       Date:  2015-01       Impact factor: 2.375

4.  Impact of hepatitis B immunization among the Nicobarese tribe--antibody titres & seroprotection five years after vaccination.

Authors:  A P Sugunan; Haimanti Bhattacharya; Debdutta Bhattacharya; A Mandal; S R Ghosal; R C Rao; A K Mandal
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.